These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 11790232)

  • 1. T2 hypointensity in the deep gray matter of patients with multiple sclerosis: a quantitative magnetic resonance imaging study.
    Bakshi R; Benedict RH; Bermel RA; Caruthers SD; Puli SR; Tjoa CW; Fabiano AJ; Jacobs L
    Arch Neurol; 2002 Jan; 59(1):62-8. PubMed ID: 11790232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive impairment is associated with subcortical magnetic resonance imaging grey matter T2 hypointensity in multiple sclerosis.
    Brass SD; Benedict RH; Weinstock-Guttman B; Munschauer F; Bakshi R
    Mult Scler; 2006 Aug; 12(4):437-44. PubMed ID: 16900757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gray matter T2 hypointensity is related to plaques and atrophy in the brains of multiple sclerosis patients.
    Bakshi R; Dmochowski J; Shaikh ZA; Jacobs L
    J Neurol Sci; 2001 Mar; 185(1):19-26. PubMed ID: 11266686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deep grey matter "black T2" on 3 tesla magnetic resonance imaging correlates with disability in multiple sclerosis.
    Zhang Y; Zabad R; Wei X; Metz L; Hill M; Mitchell J
    Mult Scler; 2007 Aug; 13(7):880-3. PubMed ID: 17468444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI T2 hypointensity of the dentate nucleus is related to ambulatory impairment in multiple sclerosis.
    Tjoa CW; Benedict RH; Weinstock-Guttman B; Fabiano AJ; Bakshi R
    J Neurol Sci; 2005 Jul; 234(1-2):17-24. PubMed ID: 15993137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3T deep gray matter T2 hypointensity correlates with disability over time in stable relapsing-remitting multiple sclerosis: a 3-year pilot study.
    Zhang Y; Metz LM; Yong VW; Mitchell JR
    J Neurol Sci; 2010 Oct; 297(1-2):76-81. PubMed ID: 20708201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T2 hypointensity in the deep gray matter of patients with benign multiple sclerosis.
    Ceccarelli A; Filippi M; Neema M; Arora A; Valsasina P; Rocca MA; Healy BC; Bakshi R
    Mult Scler; 2009 Jun; 15(6):678-86. PubMed ID: 19482861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of T2 intensity by magnetic resonance imaging of deep gray matter nuclei in multiple sclerosis patients: effect of immunomodulatory therapies.
    Pawate S; Wang L; Song Y; Sriram S
    J Neuroimaging; 2012 Apr; 22(2):137-44. PubMed ID: 21707826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sample size requirements for one-year treatment effects using deep gray matter volume from 3T MRI in progressive forms of multiple sclerosis.
    Kim G; Chu R; Yousuf F; Tauhid S; Stazzone L; Houtchens MK; Stankiewicz JM; Severson C; Kimbrough D; Quintana FJ; Chitnis T; Weiner HL; Healy BC; Bakshi R
    Int J Neurosci; 2017 Nov; 127(11):971-980. PubMed ID: 28100092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thalamic Iron Differentiates Primary-Progressive and Relapsing-Remitting Multiple Sclerosis.
    Burgetova A; Dusek P; Vaneckova M; Horakova D; Langkammer C; Krasensky J; Sobisek L; Matras P; Masek M; Seidl Z
    AJNR Am J Neuroradiol; 2017 Jun; 38(6):1079-1086. PubMed ID: 28450431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcranial brain sonography findings predict disease progression in multiple sclerosis.
    Walter U; Wagner S; Horowski S; Benecke R; Zettl UK
    Neurology; 2009 Sep; 73(13):1010-7. PubMed ID: 19657105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deep gray matter atrophy in multiple sclerosis: a tensor based morphometry.
    Tao G; Datta S; He R; Nelson F; Wolinsky JS; Narayana PA
    J Neurol Sci; 2009 Jul; 282(1-2):39-46. PubMed ID: 19168189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron deposition in the gray matter in patients with relapse-remitting multiple sclerosis: A longitudinal study using three-dimensional (3D)-enhanced T2*-weighted angiography (ESWAN).
    Du S; Sah SK; Zeng C; Wang J; Liu Y; Xiong H; Li Y
    Eur J Radiol; 2015 Jul; 84(7):1325-32. PubMed ID: 25959392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study.
    Tedeschi G; Dinacci D; Comerci M; Lavorgna L; Savettieri G; Quattrone A; Livrea P; Patti F; Morra VB; Servillo G; Orefice G; Paciello M; Prinster A; Coniglio G; Bonavita S; Di Costanzo A; Bellacosa A; Valentino P; Quarantelli M; Brunetti A; Salemi G; D'Amelio M; Simone I; Salvatore M; Bonavita V; Alfano B
    Mult Scler; 2009 Feb; 15(2):204-11. PubMed ID: 18987104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A semiautomated measure of whole-brain atrophy in multiple sclerosis.
    Bermel RA; Sharma J; Tjoa CW; Puli SR; Bakshi R
    J Neurol Sci; 2003 Apr; 208(1-2):57-65. PubMed ID: 12639726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression of regional grey matter atrophy in multiple sclerosis.
    Eshaghi A; Marinescu RV; Young AL; Firth NC; Prados F; Jorge Cardoso M; Tur C; De Angelis F; Cawley N; Brownlee WJ; De Stefano N; Laura Stromillo M; Battaglini M; Ruggieri S; Gasperini C; Filippi M; Rocca MA; Rovira A; Sastre-Garriga J; Geurts JJG; Vrenken H; Wottschel V; Leurs CE; Uitdehaag B; Pirpamer L; Enzinger C; Ourselin S; Gandini Wheeler-Kingshott CA; Chard D; Thompson AJ; Barkhof F; Alexander DC; Ciccarelli O
    Brain; 2018 Jun; 141(6):1665-1677. PubMed ID: 29741648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of 7 T MRI to assess atrophy of the subcortical deep gray matter in relapsing-remitting multiple sclerosis.
    Callen AM; Zurawski J; Chu R; Tie Y; Tauhid S; Quattrucci M; Healy BC; Bakshi R
    J Neurol; 2024 Oct; 271(10):6935-6943. PubMed ID: 39240345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impact of Intracortical Lesions on Volumes of Subcortical Structures in Multiple Sclerosis.
    Kalinin I; Makshakov G; Evdoshenko E
    AJNR Am J Neuroradiol; 2020 May; 41(5):804-808. PubMed ID: 32381540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of longitudinal brain atrophy in multiple sclerosis by gray matter magnetic resonance imaging T2 hypointensity.
    Bermel RA; Puli SR; Rudick RA; Weinstock-Guttman B; Fisher E; Munschauer FE; Bakshi R
    Arch Neurol; 2005 Sep; 62(9):1371-6. PubMed ID: 16157744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional brain atrophy is associated with physical disability in multiple sclerosis: semiquantitative magnetic resonance imaging and relationship to clinical findings.
    Bakshi R; Benedict RH; Bermel RA; Jacobs L
    J Neuroimaging; 2001 Apr; 11(2):129-36. PubMed ID: 11296581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.